Ocular surface disease is a major eye disease among the Indians. But this is the problem nobody seems to be interested in. This drives Dr. Virender S. Sangwan, MS in the L.V. Prasad Eye Institute to come forward to take necessary steps. As a result, he works at trying to make the lives of patients easier through stem cell transplantation at the Institute.And now the hospital has become a ray of hope for many.
Dr. Sangwan is becoming a pioneer in treating ocular surface disease through corneal regeneration using limbal stem cell transplantation. He completed 2 years in corneal regeneration, which included uveitis and ocular inflammatory diseases, before returning to India, where L.V. Prasad offered him a position as the cornea specialist. When the uveitis/retina specialist left, Dr. Sangwan served under both subspecialties.
Dr. Sangwan found a partner in Geeta K. Vemuganti, DCP, MD, DNB. Together, they worked for 1 year. Through the clinical trial, Drs. Sangwan and Vemuganti found that they could successfully grow the cells and transplant them to the human eye, where they can repair damaged epithelium and corneas and allow patients to see again.
As a result of the effort, both were awarded the Dr. Sangwan was awarded the Shanti Swaroop Bhatnagar award, which is the highest award in India for science and technology.He said there is a high success rate when the injury or disease is moderately severe, and the center is seeing an increase in the referrals, both from the surrounding area and throughout the country.
Source: OSN Super Site
Filed under Eye Diseases, Eye Treatment, Ocular Surface Disease, Stem cell | Tags: corneal regeneration, eye, Eye institute, LV Prasad Eye Institute, Ocular Surface Disease, Shanti Swaroop Bhatnagar award, uveitis and ocular inflammatory diseases | Comment Below